Tag Archives: Colorado Civil Rights Commission

David Davenport: Let Him Bake Cake

You may remember the baker Jack Phillips in Colorado. As a Christian, Philips felt he could not in good conscience decorate cakes celebrating events that did not square with his beliefs.  The Colorado Civil Rights Commission opposed him and, finally, the US Supreme Court said the Commission had acted prejudicially.

But within weeks of the Court’s decision, the Civil Rights Commission brought another case against Phillips for declining to customize a cake celebrating a gender transition.  One Commissioner took to Twitter calling him a “hater.”

Finally, after six and a half years, the Commission has decided to withdraw its complaint and let him bake cakes in peace.  Perhaps the change from Supreme Court Justice Anthony Kennedy to Brett Kavanaugh was a reality check.

First Amendment religious rights and Fourteenth Amendment civil rights are sometimes in tension, but religious rights must not be put down by government agencies.

Read More »

Masterpiece Cakeshop Owner Talks Victory at Supreme Court

Townhall Review — June 09, 2018 

Hugh Hewitt and Michael Medved speak with Jack Phillips, owner of The Masterpiece Cake Shop, and ADF lead council, Kristin Waggoner, to recount their six-year battle against the Colorado Civil Rights Commission and the Supreme Court’s groundbreaking ruling in favor of religious liberty. Michael Medved discusses the “Me Too” Movement’s next target, Bill Clinton. 98.9 FM The Answer’s Chuck Douglas speaks with Vice President Mike Pence for an insider view into what it’s like to be President Trump’s #2. Dennis Prager discusses the modern evangelicals’ unsettling exodus from the primary shaping force of Christianity, the Bible. Hugh Hewitt presses US Attorney General Jeff Sessions to explain the policy for separating immigrant children from their parents after they cross the border illegally. Mike Gallagher discusses the Democrats’ opposition to the President’s “right to try” law which grants terminally ill patients access to experimental treatments that have not yet been cleared by the FDA.

Read More »